S&P 500

5.460,48

-0,41%

Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.

Registrieren

QBIO

Q BioMed (CE) (QBIO)

Q BioMed Inc (CE)

Von:

Regulatory News

Text Search:

Sortieren nach:

Non-Regulatory News

Showing the most relevant articles for your search:USOTC:QBIO

1 2 3 4 5 6 Next >>

Datum	Zeit	Quelle	Überschrift	Symbol	Firma
16/06/2023	22h01	Edgar (US Regulatory)	Quarterly Report (10-q)	USOTC:QBIO	Q BioMed Inc (CE)
26/05/2023	22h56	Edgar (US Regulatory)	Annual Report (10-k)	USOTC:QBIO	Q BioMed Inc (CE)
01/03/2023	19h02	Edgar (US Regulatory)	Notification That Annual Report Will Be Submitted Late (nt 10-k)	USOTC:QBIO	Q BioMed Inc (CE)
07/12/2022	21h01	Edgar (US Regulatory)	Information Statement - All Other (definitive) (def 14c)	USOTC:QBIO	Q BioMed Inc (CE)
18/11/2022	23h16	Edgar (US Regulatory)	Current Report Filing (8-k)	USOTC:QBIO	Q BioMed Inc (CE)
03/11/2022	21h04	Edgar (US Regulatory)	Quarterly Report (10-q)	USOTC:QBIO	Q BioMed Inc (CE)
28/07/2022	22h19	Edgar (US Regulatory)	Quarterly Report (10-q)	USOTC:QBIO	Q BioMed Inc (CE)
15/07/2022	23h01	Edgar (US Regulatory)	Notification That Quarterly Report Will Be Submitted Late (nt 10-q)	USOTC:QBIO	Q BioMed Inc (CE)
13/05/2022	22h35	Edgar (US Regulatory)	Current Report Filing (8-k)	USOTC:QBIO	Q BioMed Inc (CE)
14/04/2022	23h01	Edgar (US Regulatory)	Quarterly Report (10-q)	USOTC:QBIO	Q BioMed Inc (CE)
25/01/2022	17h33	Edgar (US Regulatory)	Current Report Filing (8-k)	USOTC:QBIO	Q BioMed Inc (CE)
11/01/2022	22h36	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	USOTC:QBIO	Q BioMed Inc (CE)
15/10/2021	22h19	Edgar (US Regulatory)	Quarterly Report (10-q)	USOTC:QBIO	Q BioMed Inc (CE)
07/10/2021	18h27	Edgar (US Regulatory)	Current Report Filing (8-k)	USOTC:QBIO	Q BioMed Inc (CE)
30/07/2021	22h31	Edgar (US Regulatory)	Current Report Filing (8-k)	USOTC:QBIO	Q BioMed Inc (CE)
10/05/2021	22h10	Edgar (US Regulatory)	Current Report Filing (8-k)	USOTC:QBIO	Q BioMed Inc (CE)
14/04/2021	23h29	Edgar (US Regulatory)	Quarterly Report (10-q)	USOTC:QBIO	Q BioMed Inc (CE)
26/02/2021	18h52	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	USOTC:QBIO	Q BioMed Inc (CE)
16/02/2021	23h28	Edgar (US Regulatory)	Current Report Filing (8-k)	USOTC:QBIO	Q BioMed Inc (CE)
05/02/2021	12h02	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	USOTC:QBIO	Q BioMed Inc (CE)
11/01/2021	12h01	Edgar (US Regulatory)	Securities Registration Statement (s-1)	USOTC:QBIO	Q BioMed Inc (CE)
29/12/2020	19h07	Edgar (US Regulatory)	Current Report Filing (8-k)	USOTC:QBIO	Q BioMed Inc (CE)
19/11/2020	21h49	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	USOTC:QBIO	Q BioMed Inc (CE)
19/11/2020	21h48	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	USOTC:QBIO	Q BioMed Inc (CE)
14/10/2020	22h58	Edgar (US Regulatory)	Quarterly Report (10-q)	USOTC:QBIO	Q BioMed Inc (CE)
15/09/2020	14h53	InvestorsHub NewsWire	Q BioMed Announces Strontium89 Initial Uptake and Momentum in US and Europe	USOTC:QBIO	Q BioMed Inc (CE)
26/08/2020	13h30	InvestorsHub NewsWire	Q BioMed Announces Initiation of GMP Production of Novel COVID-19 Therapeutic for Clinical Trial Program	USOTC:QBIO	Q BioMed Inc (CE)
11/08/2020	14h05	InvestorsHub NewsWire	Q BioMed Announces Strontium89 will be available as of September 2020 through Named Patient Program for Bone Metastases Pain	USOTC:QBIO	Q BioMed Inc (CE)
15/07/2020	22h58	Edgar (US Regulatory)	Quarterly Report (10-q)	USOTC:QBIO	Q BioMed Inc (CE)
11/06/2020	18h13	Edgar (US Regulatory)	Statement of Ownership (sc 13g)	USOTC:QBIO	Q BioMed Inc (CE)